Fredun Pharmaceuticals has informed that Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has done allotment of convertible warrants on Preferential Basis to Non-Promoters on May 2, 2023. Further, the Warrant Holders have paid the balance of the consideration aggregating to Rs 2,38,34,085 and have applied for exercising their rights for conversion of 47,850 warrants into equivalent number of Equity Shares. Consequently, the Board of Directors in its meeting held today i.e., May 02, 2023 has allotted 47,850 Equity Shares of face value Rs 10 each to the warrant holders.
The above information is a part of company’s filings submitted to BSE.
